Statistics of Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease.

Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloadsGenerated via ORBi - 18/05/2025
Loading...
Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloads by countryGenerated via ORBi - 18/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of viewsGenerated via ORBi - 18/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of views by countryGenerated via ORBi - 18/05/2025
Loading...
Created with Highcharts 9.2.2Chart context menuOrigin of ORBi's visitorsGenerated via ORBi - 18/05/2025
Loading...
Contact ORBi